Please login to the form below
Aprecia
This page shows the latest Aprecia news and features for those working in and with pharma, biotech and healthcare.
3D printed epilepsy drug launched in the US
Aprecia’s Spritam is now available as a prescription drug. The first ever drug manufactured using 3D printing technology is now available to US patients with epilepsy. ... Aprecia Pharmaceutical's Spritam was approved by the FDA in August last year,
Latest news
-
Printable pharma
Spritam is designed to fill a need for patients who struggle with their current medication experience,” commented Don Wetherhold, Aprecia's chief executive. ... This is the first in a line of central nervous system products Aprecia plans to introduce
-
FDA approves world’s first 3D printed drug
The drug Spritam (levetiracetam), from Aprecia Pharmaceuticals, has been given the green light from the US regulator as an adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and ... experience. "This is the first in a line
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Featured jobs
- Experienced / Senior Medical Writer - MedComms - Cardiff - Wales
-
Excellent Salary and Benefits on offer
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Salary TBC
- Scientific Director - Medical Communications Agency - New York
-
Excellent Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
- Senior Medical Writer – Leading Medical Communications Agency – ...
-
Highly Competitive Remuneration Package
- Scientific Director - Medical Education - Cheshire & London ...
-
Excellent Remuneration Package
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Graduate / Entry Level Opportunities – Medical Communications – ...
-
Highly Competitive Remuneration Package
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Senior / Principal Medical Writer – Medical Education - UK &...
-
Excellent Salary and Benefits on offer
Subscribe to our email news alerts
- AstraZeneca’s Calquence impresses in previously untreated CLL
- Armed with new data, BMS plans filings for Celgene CAR-T liso-cel
- Sangamo steps up BioMarin chase with haemophilia gene therapy data
- PMEA 2019 Winners Gallery
- Sanofi’s new CEO cuts first deal, adding Synthorx for $2.5bn
- J&J and Bristol-Myers Squibb/Bluebird bio reveal rival CAR-T data
- Frontera proud finalists for the 2020 PM Awards
- Brexit nears as Conservatives sweep to victory in election
- Roche’s Tecentriq combo scores in first-line melanoma
- House Democrats finally pass landmark drug pricing bill
- UPDATED: Senate officially confirms Stephen Hahn as FDA commissioner
- FDA grants surprise OK to Sarepta’s DMD therapy after earlier rejection
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...
Latest intelligence
- The 2019 CPhI Pharma Index Report
- Examining this year’s industry performance...
- Five key trends in precision and personalised healthcare
- Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
- OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
- Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Quick links
Infographics
